SCHEMBL17452274

SCHEMBL17452274

COC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCc1ccccc1)NC(=O)CN1CCOCC1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTRL P40313 3/20 0.70
TMPRSS11D O60235 2/20 0.70
PSMB5 P28074 13/20 0.69
PSMB8 P28062 3/20 0.69
CYP3A4 P08684 2/20 0.69
CYP3A5 P20815 2/20 0.69
CYP3A7 P24462 2/20 0.69
CYP3A43 Q9HB55 2/20 0.69
PSMB9 P28065 2/20 0.69
PSMB10 P40306 2/20 0.69
PSMB2 P49721 2/20 0.69
PSMB11 A5LHX3 1/20 0.69
PSMD11 O00231 1/20 0.69
PSMD12 O00232 1/20 0.69
PSMD14 O00487 1/20 0.69
PSMA7 O14818 1/20 0.69
PSMD3 O43242 1/20 0.69
CTSB P07858 1/20 0.69
PSMC3 P17980 1/20 0.69
PSMB1 P20618 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19762063 0.95 TMPRSS11D (0.76) CTRLTMPRSS11DPSMB5PSMB8CYP3A4
SCHEMBL21229438 0.95 TMPRSS11D (0.76) CTRLTMPRSS11DPSMB5PSMB8CYP3A4
SCHEMBL17629505 0.95 TMPRSS11D (0.76) CTRLTMPRSS11DPSMB5PSMB8CYP3A4
SCHEMBL17629503 0.95 TMPRSS11D (0.76) CTRLTMPRSS11DPSMB5PSMB8CYP3A4
SCHEMBL10083436 0.95 TMPRSS11D (0.76) CTRLTMPRSS11DPSMB5PSMB8CYP3A4
SCHEMBL23616283 0.95 TMPRSS11D (0.76) CTRLTMPRSS11DPSMB5PSMB8CYP3A4
SCHEMBL8080980 0.95 TMPRSS11D (0.76) CTRLTMPRSS11DPSMB5PSMB8CYP3A4
SCHEMBL15634572 0.91 TMPRSS11D (0.73) CTRLTMPRSS11DPSMB5PSMB8CYP3A4
SCHEMBL15634574 0.91 TMPRSS11D (0.73) CTRLTMPRSS11DPSMB5PSMB8CYP3A4
SCHEMBL17452276 0.91 TMPRSS11D (0.73) CTRLTMPRSS11DPSMB5PSMB8CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10787482-B2 Epoxyketone compounds for enzyme inhibition Centrax International Inc. (US) 2020-09-29 US disclosed
US-10640533-B2 Epoxyketone compounds for enzyme inhibition CENTRAX INTERNATIONAL, INC. (US) 2020-05-05 US disclosed
US-20200087343-A1 EPOXYKETONE COMPOUNDS FOR ENZYME INHIBITION CENTRAX INTERNATIONAL, INC. (US) 2020-03-19 US disclosed
EP-3166933-B1 EPOXYKETONE COMPOUNDS FOR ENZYME INHIBITION CENTRAX INT INC (US) 2018-08-01 EP disclosed
US-20170158734-A1 EPOXYKETONE COMPOUNDS FOR ENZYME INHIBITION CENTRAX INTERNATIONAL, INC. (US) 2017-06-08 US disclosed
WO-2016011088-A2 EPOXYKETONE COMPOUNDS FOR ENZYME INHIBITION CENTRAX INTERNATIONAL, INC. (US) 2016-01-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10787482-B2 Epoxyketone compounds for enzyme inhibition PSMD10, PSMC1, PSMB10 CTRL 532/4885TMPRSS11D 946/4885PSMB5 13/4885
US-10640533-B2 Epoxyketone compounds for enzyme inhibition PSMD10, PSMC1, PSMB10 CTRL 532/4885TMPRSS11D 946/4885PSMB5 13/4885
US-20170158734-A1 EPOXYKETONE COMPOUNDS FOR ENZYME INHIBITION PSMD10, PSMC1, PSMB10 CTRL 532/4885TMPRSS11D 946/4885PSMB5 13/4885
US-20200087343-A1 EPOXYKETONE COMPOUNDS FOR ENZYME INHIBITION PSMD10, PSMC1, PSMB10 CTRL 532/4885TMPRSS11D 946/4885PSMB5 13/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.